CLINICAL BENEFITS OF TRAMIPROSATE IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH HIGHER NUMBER OF APOE4 ALLELES: THE “APOE4 GENE-DOSE EFFECT.” J Prev Alzheimer’s Dis

Abushakra S, Porsteinsson A, Vellas B, Cummings J, Gauthier S, Hey JA

January 2016